Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement

  1. U.S. Preventive Services Task Force*
  1. From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
    1. Figure.
      View larger version:
      Figure. Screening for gestational diabetes mellitus (GDM): clinical summary of U. S. Preventive Services Task Force Recommendation.

      For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement (including a summary of research gaps), and supporting documents, please go to http://www.preventiveservices.ahrq.gov. *The current evidence is insufficient to establish the balance of benefits and harms for screening for gestational diabetes mellitus, either before or after 24 weeks' gestation.

    Summary for Patients

    « Previous | Next Article »Table of Contents